Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-06
A
Annick De Loose
Role not yet determined Is this you? Add your title
Also affiliated: University of Arkansas Medical Center (2023)
6 h-index
68 pubs
136 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Annick De Loose's research focuses on the application of precision medicine strategies to treat cancer. She has investigated the use of tumor organoid modeling and comparative transcriptomics to identify personalized treatment approaches, particularly for glioblastoma. Her work includes the development of biobanks for brain tumor samples to facilitate precision medicine research. De Loose has also explored therapeutic targets and oncogenic pathways in lymphoma and has contributed to research on the anti-melanoma activity of novel compounds.
Her research publications span areas including functional precision medicine pipelines, biobank development for cancer research, and the identification of therapeutic targets. De Loose has a track record of 68 publications with 135 citations and an h-index of 6. She actively collaborates with researchers at the University of Arkansas for Medical Sciences, including Vijay Patel, Sydnye L. Shuttleworth, Ying-Zhi Xu, and Claire Doshier, with whom she shares 43 co-authored publications.
Metrics
- h-index: 6
- Publications: 68
- Citations: 136
Selected Publications
-
Longitudinal multi-omics characterization of the malignant evolution in multirelapsing glioblastoma (2026)
-
Abstract 2834: Establishment of orthotopic high grade glioma xenograft model using zebrafish embryos (2024)
Collaboration Network
Top Collaborators
Analiz Rodriguez
University of Arkansas for Medical Sciences
11 shared publications
In database
- A novel Cas9-targeted long-read assay for simultaneous detection of IDH1/2 mutations and clinically relevant MGMT methylation in fresh biopsies of diffuse glioma
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Showing 5 of 11 shared publications
Olena M. Vaske
University of California, Santa Cruz (US)
4 shared publications
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- EPCO-23. COMPARATIVE TRANSCRIPTOMICS TO IDENTIFY TARGETED THERAPY CANDIDATES IN HIGH GRADE GLIOMA
- 323 Generation of a functional precision medicine pipeline which combines comparative transcriptomics and tumor organoid modeling to identify bespoke treatment strategies for glioblastoma
- Longitudinal multi-omics characterization of the malignant evolution in multirelapsing glioblastoma
Katrina Learned
University of California, Santa Cruz (US)
4 shared publications
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- EPCO-23. COMPARATIVE TRANSCRIPTOMICS TO IDENTIFY TARGETED THERAPY CANDIDATES IN HIGH GRADE GLIOMA
- 323 Generation of a functional precision medicine pipeline which combines comparative transcriptomics and tumor organoid modeling to identify bespoke treatment strategies for glioblastoma
- Longitudinal multi-omics characterization of the malignant evolution in multirelapsing glioblastoma
Emilie Darrigues
University of Arkansas for Medical Sciences
4 shared publications
In database
- Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
- Genomic and Transcriptomic Profiling of Brain Metastases
- Longitudinal multi-omics characterization of the malignant evolution in multirelapsing glioblastoma
Madison P. Lee
University of Arkansas for Medical Sciences
4 shared publications
In database
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
- Genomic and Transcriptomic Profiling of Brain Metastases
Christopher P. Wardell
University of Arkansas for Medical Sciences
4 shared publications
In database
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- Genomic and Transcriptomic Profiling of Brain Metastases
- 323 Generation of a functional precision medicine pipeline which combines comparative transcriptomics and tumor organoid modeling to identify bespoke treatment strategies for glioblastoma
- Longitudinal multi-omics characterization of the malignant evolution in multirelapsing glioblastoma
John Day
University of Arkansas for Medical Sciences (US)
3 shared publications
- A novel Cas9-targeted long-read assay for simultaneous detection of IDH1/2 mutations and clinically relevant MGMT methylation in fresh biopsies of diffuse glioma
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
- EPCO-23. COMPARATIVE TRANSCRIPTOMICS TO IDENTIFY TARGETED THERAPY CANDIDATES IN HIGH GRADE GLIOMA
Murat Gökden
University of Arkansas for Medical Sciences
3 shared publications
In database
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
- Genomic and Transcriptomic Profiling of Brain Metastases
Robert L. Eoff
University of Arkansas for Medical Sciences
3 shared publications
In database
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion
- 323 Generation of a functional precision medicine pipeline which combines comparative transcriptomics and tumor organoid modeling to identify bespoke treatment strategies for glioblastoma
Kelsey Hundley
University of Arkansas for Medical Sciences
2 shared publications
In database
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- EPCO-23. COMPARATIVE TRANSCRIPTOMICS TO IDENTIFY TARGETED THERAPY CANDIDATES IN HIGH GRADE GLIOMA
Holly C. Beale
University of California, Santa Cruz (US)
2 shared publications
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- EPCO-23. COMPARATIVE TRANSCRIPTOMICS TO IDENTIFY TARGETED THERAPY CANDIDATES IN HIGH GRADE GLIOMA
Ellen Kephart
University of California, Santa Cruz (US)
2 shared publications
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- EPCO-23. COMPARATIVE TRANSCRIPTOMICS TO IDENTIFY TARGETED THERAPY CANDIDATES IN HIGH GRADE GLIOMA
Alan J. Tackett
University of Arkansas for Medical Sciences
2 shared publications
In database
- Genomic and Transcriptomic Profiling of Brain Metastases
- Synthesis and Anti‐Melanoma Activity of Acryloyl Pyridinone Analogues
Megan R. Reed
University of Arkansas for Medical Sciences
2 shared publications
In database
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- 323 Generation of a functional precision medicine pipeline which combines comparative transcriptomics and tumor organoid modeling to identify bespoke treatment strategies for glioblastoma
A. Geoffrey Lyle
University of California, Santa Cruz (US)
2 shared publications
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- 323 Generation of a functional precision medicine pipeline which combines comparative transcriptomics and tumor organoid modeling to identify bespoke treatment strategies for glioblastoma
Similar Researchers
Based on overlapping research topics
Madison P. Lee
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Disease Models, Animal
Bioinformatics and Genomic Networks
R W Petty
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Disease Models, Animal
Cancer Cells and Metastasis
Lauren Eads
University of Arkansas for Medical Sciences
Disease Models, Animal
Cancer Cells and Metastasis
Genomics and Chromatin Dynamics
Megan R. Reed
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Disease Models, Animal
Genomics and Chromatin Dynamics
Binsheng Gong
National Center for Toxicological Research
Disease Models, Animal
Bioinformatics and Genomic Networks
Cancer Genomics and Diagnostics
Shanique Murray
University of Arkansas at Fayetteville
Disease Models, Animal
Cancer Cells and Metastasis
Genomics and Chromatin Dynamics